Health care burden of access barriers to epilepsy care in the United States: A claims-based analysis of payer channels

20250 citationsJournal Articlehybrid Open Access

Authors

Herbert Peeples · UCB Pharma (United States)

Emily Achter · STATinMED (United States)

Christopher Dieyi · STATinMED (United States)

Keshia Maughn · STATinMED (United States)

Abstract

Data revealed difficulties in neurologist access and predominant use of second-generation ASMs, despite access restrictions for many PWE, suggesting obstacles in accessing treatment and specialist care.

Topics & Keywords

Epilepsy research and treatment Pharmacological Effects and Toxicity Studies Pharmaceutical studies and practices

Publication Details

Published in: Epilepsy Research

Volume 218, pp. 107639-107639

DOI: 10.1016/j.eplepsyres.2025.107639

Field-Weighted Citation Impact: 0.00

Command Palette

Health care burden of access barriers to epilepsy care in the United States: A claims-based analysis of payer channels

Authors

Abstract

Topics & Keywords

Publication Details